IMGN logo

ImmunoGen (IMGN) Current Assets

Annual Current Assets

$304.12 M
-$195.88 M-39.18%

December 31, 2022


Summary


Performance

IMGN Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNbalance sheetmetrics:

Quarterly Current Assets

$766.90 M
+$97.63 M+14.59%

September 30, 2023


Summary


Performance

IMGN Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

IMGN Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.2%+132.1%
3 y3 years+45.6%+249.7%
5 y5 years+10.1%+137.6%

IMGN Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-39.2%at lowat high-68.2%
5 y5-year-39.2%-31.3%at high-72.8%
alltimeall time-39.2%-99.3%at high-99.8%

ImmunoGen Current Assets History

DateAnnualQuarterly
Sep 2023
-
$766.90 M(+14.6%)
Jun 2023
-
$669.27 M(+174.4%)
Mar 2023
-
$243.86 M(-19.8%)
Dec 2022
$44.81 M(+73.9%)
$304.12 M(-8.0%)
Sep 2022
-
$330.42 M(-16.1%)
Jun 2022
-
$393.92 M(-13.7%)
Mar 2022
-
$456.72 M(-8.7%)
Dec 2021
$25.77 M(-16.4%)
$500.00 M(+84.6%)
Sep 2021
-
$270.89 M(-1.3%)
Jun 2021
-
$274.40 M(-14.1%)
Mar 2021
-
$319.57 M(-1.4%)
Dec 2020
$30.82 M(+16.9%)
$324.25 M(+47.8%)
Sep 2020
-
$219.33 M(-9.1%)
Jun 2020
-
$241.37 M(-10.8%)
Mar 2020
-
$270.73 M(+29.6%)
Dec 2019
$26.36 M(+58.8%)
$208.90 M(-7.4%)
Sep 2019
-
$225.68 M(-13.0%)
Jun 2019
-
$259.38 M(-10.5%)
Mar 2019
-
$289.83 M(+4.0%)
Dec 2018
$16.60 M(-9.5%)
$278.78 M(-13.6%)
Sep 2018
-
$322.71 M(-11.5%)
Jun 2018
-
$364.62 M(+47.4%)
Mar 2018
-
$247.43 M(-10.5%)
Dec 2017
$18.34 M(-18.6%)
$276.34 M(+33.5%)
Sep 2017
-
$206.96 M(+28.2%)
Jun 2017
-
$161.41 M(+13.6%)
Mar 2017
-
$142.13 M(-31.4%)
Dec 2016
$22.52 M(-13.8%)
-
Sep 2016
-
$207.28 M(-18.1%)
Jun 2016
$26.13 M(+51.7%)
$253.11 M(+30.9%)
Mar 2016
-
$193.30 M(-13.4%)
Dec 2015
-
$223.25 M(-14.8%)
Sep 2015
-
$262.02 M(-10.0%)
Jun 2015
$17.23 M(+18.3%)
$291.02 M(+144.3%)
Mar 2015
-
$119.13 M(+4.2%)
Dec 2014
-
$114.36 M(-10.9%)
Sep 2014
-
$128.33 M(-14.9%)
Jun 2014
$14.56 M(+12.8%)
$150.76 M(-12.5%)
Mar 2014
-
$172.34 M(-9.0%)
Dec 2013
-
$189.46 M(+0.9%)
Sep 2013
-
$187.74 M(-6.5%)
Jun 2013
$12.91 M(-8.0%)
$200.68 M(-7.0%)
Mar 2013
-
$215.71 M(-0.6%)
Dec 2012
-
$217.06 M(-9.1%)
Sep 2012
-
$238.82 M(+43.6%)
Jun 2012
$14.04 M(-12.9%)
$166.27 M(-8.5%)
Mar 2012
-
$181.81 M(-6.1%)
Dec 2011
-
$193.58 M(+5.4%)
Sep 2011
-
$183.61 M(-8.9%)
Jun 2011
$16.12 M(-19.8%)
$201.53 M(+61.1%)
Mar 2011
-
$125.08 M(-8.0%)
Dec 2010
-
$135.92 M(+33.0%)
Sep 2010
-
$102.23 M(-12.7%)
Jun 2010
$20.09 M(-15.7%)
$117.12 M(+144.0%)
Mar 2010
-
$48.01 M(-18.0%)
Dec 2009
-
$58.53 M(-11.3%)
Sep 2009
-
$65.95 M(-14.2%)
Jun 2009
$23.84 M(-12.7%)
$76.87 M(+58.2%)
Mar 2009
-
$48.60 M(-7.8%)
Dec 2008
-
$52.71 M(+1.9%)
Sep 2008
-
$51.75 M(-7.7%)
Jun 2008
$27.30 M(+228.1%)
$56.04 M(+4.9%)
Mar 2008
-
$53.43 M(-10.0%)
Dec 2007
-
$59.39 M(-10.9%)
Sep 2007
-
$66.69 M(-7.5%)
Jun 2007
$8.32 M
$72.10 M(-5.2%)
Mar 2007
-
$76.05 M(-3.1%)
DateAnnualQuarterly
Dec 2006
-
$78.49 M(-2.7%)
Sep 2006
-
$80.68 M(-4.6%)
Jun 2006
$9.58 M(-6.0%)
$84.54 M(-9.1%)
Mar 2006
-
$92.97 M(-1.6%)
Dec 2005
-
$94.45 M(-1.9%)
Sep 2005
-
$96.26 M(-3.7%)
Jun 2005
$10.20 M(+1.5%)
$99.94 M(-3.4%)
Mar 2005
-
$103.50 M(-1.5%)
Dec 2004
-
$105.11 M(-2.9%)
Sep 2004
-
$108.20 M(-3.9%)
Jun 2004
$10.04 M(+7.1%)
$112.59 M(-3.0%)
Mar 2004
-
$116.08 M(+1.8%)
Dec 2003
-
$114.02 M(-1.9%)
Sep 2003
-
$116.20 M(+6.9%)
Jun 2003
$9.38 M(+39.0%)
$108.65 M(-7.3%)
Mar 2003
-
$117.17 M(-8.7%)
Dec 2002
-
$128.37 M(-6.3%)
Sep 2002
-
$137.00 M(-5.8%)
Jun 2002
$6.75 M(-88.7%)
$145.41 M(-3.5%)
Mar 2002
-
$150.73 M(-5.0%)
Dec 2001
-
$158.70 M(-0.7%)
Sep 2001
-
$159.76 M(+60.4%)
Jun 2001
$59.59 M(+3739.0%)
$99.58 M(-12.2%)
Mar 2001
-
$113.47 M(-28.5%)
Dec 2000
-
$158.79 M(+344.3%)
Sep 2000
-
$35.74 M(+100.9%)
Jun 2000
$1.55 M(-8.7%)
$17.79 M(+24.5%)
Mar 2000
-
$14.29 M(+14.3%)
Dec 1999
-
$12.50 M(+17.9%)
Sep 1999
-
$10.60 M(+92.7%)
Jun 1999
$1.70 M(-22.7%)
$5.50 M(+22.2%)
Mar 1999
-
$4.50 M(+12.5%)
Dec 1998
-
$4.00 M(-13.0%)
Sep 1998
-
$4.60 M(+24.3%)
Jun 1998
$2.20 M(-46.3%)
$3.70 M(-2.6%)
Mar 1998
-
$3.80 M(0.0%)
Dec 1997
-
$3.80 M(+26.7%)
Sep 1997
-
$3.00 M(+36.4%)
Jun 1997
$4.10 M(-25.5%)
$2.20 M(-26.7%)
Mar 1997
-
$3.00 M(+30.4%)
Dec 1996
-
$2.30 M(+53.3%)
Sep 1996
-
$1.50 M(-50.0%)
Jun 1996
$5.50 M(-59.9%)
$3.00 M(+11.1%)
Mar 1996
-
$2.70 M(+42.1%)
Dec 1995
-
$1.90 M(-42.4%)
Sep 1995
-
$3.30 M(0.0%)
Jun 1995
$13.70 M(-17.5%)
$3.30 M(-48.4%)
Mar 1995
-
$6.40 M(-59.5%)
Sep 1994
-
$15.80 M(-27.5%)
Jun 1994
$16.60 M(+45.6%)
$21.80 M(-21.6%)
Mar 1994
-
$27.80 M(+59.8%)
Dec 1993
-
$17.40 M(-32.6%)
Sep 1993
-
$25.80 M(-26.5%)
Jun 1993
$11.40 M(+185.0%)
$35.10 M(-16.8%)
Mar 1993
-
$42.20 M(-11.7%)
Dec 1992
-
$47.80 M(-10.5%)
Sep 1992
-
$53.40 M(-7.9%)
Jun 1992
$4.00 M(+29.0%)
$58.00 M(-7.1%)
Mar 1992
-
$62.40 M(+66.4%)
Sep 1991
-
$37.50 M(-9.2%)
Jun 1991
$3.10 M(-11.4%)
$41.30 M(+0.7%)
Mar 1991
-
$41.00 M(+400.0%)
Dec 1990
-
$8.20 M(-26.8%)
Sep 1990
-
$11.20 M(-3.4%)
Jun 1990
$3.50 M(+105.9%)
$11.60 M(-18.3%)
Mar 1990
-
$14.20 M(+140.7%)
Sep 1989
-
$5.90 M(-20.3%)
Jun 1989
$1.70 M
$7.40 M

FAQ

  • What is ImmunoGen annual total current assets?
  • What is the all time high annual current assets for ImmunoGen?
  • What is ImmunoGen annual current assets year-on-year change?
  • What is ImmunoGen quarterly total current assets?
  • What is the all time high quarterly current assets for ImmunoGen?
  • What is ImmunoGen quarterly current assets year-on-year change?

What is ImmunoGen annual total current assets?

The current annual current assets of IMGN is $304.12 M

What is the all time high annual current assets for ImmunoGen?

ImmunoGen all-time high annual total current assets is $500.00 M

What is ImmunoGen annual current assets year-on-year change?

Over the past year, IMGN annual total current assets has changed by -$195.88 M (-39.18%)

What is ImmunoGen quarterly total current assets?

The current quarterly current assets of IMGN is $766.90 M

What is the all time high quarterly current assets for ImmunoGen?

ImmunoGen all-time high quarterly total current assets is $766.90 M

What is ImmunoGen quarterly current assets year-on-year change?

Over the past year, IMGN quarterly total current assets has changed by +$436.48 M (+132.10%)